| Code | Description | Claims | Beneficiaries | Total Paid |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
27,237 |
18,469 |
$1.62M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
16,668 |
13,729 |
$1.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,540 |
12,582 |
$1.12M |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13,080 |
10,022 |
$414K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,773 |
4,125 |
$258K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
4,211 |
3,529 |
$229K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
703 |
549 |
$78K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
898 |
692 |
$39K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
403 |
312 |
$38K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
565 |
514 |
$21K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
1,887 |
1,356 |
$20K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
363 |
262 |
$14K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,791 |
673 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
871 |
674 |
$6K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16,164 |
13,043 |
$4K |
| 87807 |
|
250 |
195 |
$2K |
| S9083 |
Global fee urgent care centers |
240 |
208 |
$982.50 |
| 81002 |
|
175 |
145 |
$166.30 |